Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
50% Autologous Serum vs. Cyclosporine and Artificial Tears in Severe Dry Eye
NCT03666884Phase 4Completed
- Start
- Oct 2015
- Primary completion
- Mar 2016
- Modality
- Biologic
01
Overview
Phase 4, randomised, open-label trial of Autologous serum eye drops 20% in dry eye syndrome (DED). Primary endpoint: Schirmer's Test at 1 month. Started Oct 2015; status: completed.
02
Drugs
Autologous serum eye drops 20%
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT03666884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03666884.